MORNING SESSION Chair: Welcome – Adopting the agenda. Before we start, let me reiterate a few guidelines: limit intervention to 5 minutes, delegation from the floor please keep it short and feel strongly encouraged to comment and ask questions to the panellists, there will be no list of speakers, the floor will draw the attention of …
Chair: Good morning. I have chaired for 9 months now. It is very important that we don’t fight and say one document is more important than the other. Bear in mind that what we are building today needs to be structured but we also need to decide what we propose in December. We need to …
Chair: Good Morning. Let’s start right away with the presentations and take advantage of the opportunity to conduct interactive sessions. PANEL: Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, UNODC: Access to controlled drugs for medical purposes while preventing misuse and diversion. For long time this aspect was not paid attention so now …
Canada: it’s not the first time I’ve seen this text. We’ve done a thorough analysis and we think this is worthy of showing the COW? ‘Alt PP13bis Acknowledging that removing stigmatising attitudes includes long term comprehensive multidisciplinary and balanced efforts by member states, in full conformity with the Universal Declaration of Human Rights, the Universal …
L11 Chair: We may not move in chronological order. I want to mention I intend to continue our session in the evening because we have very little time left. I invite us to focus on L11. China: Regarding the night session we have some concerns because we have many experts who wish to speak in …
Panel: Ann Fordham, Brun González, Jane Slater, Jindřich Vobořil, Mary Catherine Alvarez, Maricela Orozco Montalvo, Suzanne Sharkey, Peter Muyshondt Jindřich Vobořil: Welcome to our event. I am the National Drug Coordinator for the Czech Republic. We combined different ways of approaching this issue. We will start with some real life stories first of all. Jane …